|
1
|
Andersen NF, Vogel U, Klausen TW, Gimsing
P, Gregersen H, Abildgaard N and Vangsted AJ: Vascular endothelial
growth factor (VEGF) gene polymorphisms may influence the efficacy
of thalidomide in multiple myeloma. Int J Cancer. 131:E636–E642.
2012. View Article : Google Scholar
|
|
2
|
Thanigaimani S, Kichenadasse G and Mangoni
AA: The emerging role of vascular endothelial growth factor (VEGF)
in vascular homeostasis: lessons from recent trials with anti-VEGF
drugs. Curr Vasc Pharmacol. 9:358–380. 2011. View Article : Google Scholar
|
|
3
|
Ferrara N and Davis-Smyth T: The biology
of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang H, Albadawi H, Siddiquee Z, Stone JM,
Panchenko MP, Watkins MT and Stone JR: Altered vascular activation
due to deficiency of the NADPH oxidase component p22phox.
Cardiovasc Pathol. 23:35–42. 2014. View Article : Google Scholar
|
|
5
|
Lepetsos P, Pampanos A, Lallos S,
Kanavakis E, Korres D, Papavassiliou AG and Efstathopoulos N:
Association of NADPH oxidase p22phox gene C242T, A640G and -930A/G
polymorphisms with primary knee osteoarthritis in the Greek
population. Mol Biol Rep. 40:5491–5499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Le NT, Corsetti JP, Dehoff-Sparks JL,
Sparks CE, Fujiwara K and Abe J: Reactive oxygen species,
SUMOylation and endothelial inflammation. Int J Inflam.
2012:6781902012. View Article : Google Scholar
|
|
7
|
Farrag W and Eid M: Association of the
C242T polymorphism of the p22 phox gene with advanced carotid
atherosclerosis in type 2 diabetes. Mol Med Rep. 1:679–684.
2008.PubMed/NCBI
|
|
8
|
Dinauer MC, Pierce EA, Bruns GA, Curnutte
JT and Orkin SH: Human neutrophil cytochrome b light chain
(p22-phox). Gene structure, chromosomal location and mutations in
cyto-chrome-negative autosomal recessive chronic granulomatous
disease. J Clin Invest. 86:1729–1737. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 35(Suppl
1): S64–S71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Safah Mokhtar S, M Vanhoutte P, WS Leung
S, Imran Yusof M, Wan Sulaiman WA, Zaharil Mat Saad A, Suppian R
and Ghulam Rasool AH: Reduced expression of prostacyclin synthase
and nitric oxide synthase in subcutaneous arteries of type 2
diabetic patients. Tohoku J Exp Med. 231:217–222. 2013. View Article : Google Scholar
|
|
11
|
Girach A, Manner D and Porta M: Diabetic
microvascular complications: Can patients at risk be identified? A
review. Int J Clin Pract. 60:1471–1483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vinik AI and Mehrabyan A: Diabetic
neuropathies. Med Clin North Am. 88:947–999. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kovac B, Kovac B, Marusić-Emedi S, Svalina
S and Demarin V: Clinical and electrophysiological signs of
diabetic polyneuropathy-effect of glycemia and duration of diabetes
mellitus. Acta Clin Croat. 50:149–157. 2011.
|
|
14
|
Hyer CF, Lee TH, Philbin TM and Berlet GC:
Diabetic neuropathy: The painful foot. Foot Ankle Clin. 9:221–237.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang B, Cross DF, Ollerenshaw M, Millward
BA and Demaine AG: Polymorphisms of the vascular endothelial growth
factor and susceptibility to diabetic microvascular complications
in patients with type 1 diabetes mellitus. J Diabetes
Complications. 17:1–6. 2003. View Article : Google Scholar
|
|
16
|
Liu XL, Yang QF and Kong BH: Vascular
endothelial growth factor +936C/T polymorphism and cancer risk in
Asians: A meta-analysis. Genet Mol Res. 12:1924–1933. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mandal RK, Yadav SS, Panda AK and Khattri
S: Vascular endothelial growth factor 936 c>T polymorphism
increased oral cancer risk: Evidence from a meta-analysis. Genet
Test Mol Biomarkers. 17:543–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oliveira C, Lourenço GJ, Silva PM,
Cardoso-Filho C, Favarelli MH, Gonçales NS, Gurgel MS and Lima CS:
Polymorphisms in the 5′- and 3′-untranslated region of the VEGF
gene and sporadic breast cancer risk and clinicopathologic
characteristics. Tumour Biol. 32:295–300. 2011. View Article : Google Scholar
|
|
19
|
Eroglu A, Gulec S and Akar N: Vascular
endothelial growth factor C936T polymorphism in cancer patients
with thrombosis. Am J Hematol. 82:1742007. View Article : Google Scholar
|
|
20
|
Xu S, Wu W, Sun H, Lu J, Yuan B, Xia Y, De
Moor B, Marchal K, Wang X, Xu P, et al: Association of the vascular
endothelial growth factor gene polymorphisms (-460C/T, +405 G/C and
+936T/C) with endometriosis: A meta-analysis. Ann Hum Genet.
76:464–471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang Y, Liang G, Wang L, Jiang J, Du G
and Huang Y: Association between vascular endothelial growth factor
+936 C/T gene polymorphism and age-related macular degeneration. J
Int Med Res. 41:317–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li BH, Zhang LL, Zhang BB, Yin YW, Dai LM,
Pi Y, Guo L, Gao CY, Fang CQ, Wang JZ, et al: Association between
NADPH oxidase p22(phox) C242T polymorphism and ischemic
cerebrovascular disease: A meta-analysis. PLoS One. 8:e564782013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Oliveira Alvin R, Santos PC, Dias RG,
Rodrigues MV, de Sa Cunha R, Mill JG, Junior WN, Krieger JE and
Pereira AC: Association between the C242T polymorphism in the
p22phox gene with arterial stiffness in the Brazilian population.
Physiol Genomics. 44:587–592. 2012. View Article : Google Scholar
|
|
24
|
Schreiber R, Ferreira-Sae MC, Ronchi JA,
Pio-Magalhães JA, Cipolli JA, Matos-Souza JR, Mill JG, Vercesi AE,
Krieger JE, Franchini KG, et al: The C242T polymorphism of the
p22-phox gene (CYBA) is associated with higher left ventricular
mass in Brazilian hypertensive patients. BMC Med Genet. 12:1142011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schächinger V, Britten MB, Dimmeler S and
Zeiher AM: NADH/NADPH oxidase p22 phox gene polymorphism is
associated with improved coronary endothelial vasodilator function.
Eur Heart J. 22:96–101. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sposito AC, Caramelli B, Fonseca FA,
Bertolami MC, Afiune Neto A, Souza AD, Lottenberg AM, Chacra AP,
Faludi AA, Loures-Vale AA, et al: IV Brazilian guideline for
dyslipidemia and atherosclerosis prevention: Department of
atherosclerosis of brazilian society of cardiology. Arq Bras
Cardiol. 88(Suppl 1): 2–19. 2007. View Article : Google Scholar
|
|
27
|
Lahiri DK and Nurnberger JI: A rapid
non-enzymatic method for the preparation of HMW DNA from blood for
RFLP studies. Nucleic Acids Res. 19:54441991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Young MJ, Boulton AJ, Macleod AF, Williams
DR and Sonksen PH: A multicentre study of the prevalence of
diabetic peripheral neuropathy in the United Kingdom hospital
clinic population. Diabetologia. 36:150–154. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Al-Geffari M: Comparison of different
screening tests for diagnosis of diabetic peripheral neuropathy in
Primary Health Care setting. Int J Health Sci (Qassim). 6:127–134.
2012. View
Article : Google Scholar
|
|
30
|
Shehab DK, Al-Jarallah KF, Abraham M,
Mojiminiyi OA, Al-Mohamedy H and Abdella NA: Back to basics: Ankle
refex in the evaluation of peripheral neuropathy in type 2 diabetes
mellitus. QJM. 105:315–320. 2012. View Article : Google Scholar
|
|
31
|
Jayaprakash P, Bhansali A, Bhansali S,
Dutta P, Anantharaman R, Shanmugasundar G and Ravikiran M:
Validation of bedside methods in evaluation of diabetic peripheral
neuropathy. Indian J Med Res. 133:645–649. 2011.PubMed/NCBI
|
|
32
|
Sumpio BE: Contemporary evaluation and
management of the diabetic foot. Scientifica (Cairo).
2012:4354872012.
|
|
33
|
Feng Y, Schlösser FJ and Sumpio BE: The
Semmes Weinstein monofilament examination is a significant
predictor of the risk of foot ulceration and amputation in patients
with diabetes mellitus. J Vasc Surg. 53:220–226. 2011. View Article : Google Scholar
|
|
34
|
Perkins BA, Orszag A, Ngo M, Ng E, New P
and Bril V: Prediction of incident diabetic neuropathy using the
monofilament examination: A 4-year prospective study. Diabetes
Care. 33:1549–1554. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
No authors listed. Obesity: Preventing and
managing the global epidemic. Report of a WHO consultation. World
Health Organ Tech Rep Ser. 894:1–253. 2000.
|
|
36
|
Sicree R and Shaw J: Type 2 diabetes: An
epidemic or not and why it is happening. Diabetol Metab Syndr.
1:75–81. 2007. View Article : Google Scholar
|
|
37
|
Kim HW, Ko GJ, Kang YS, Lee MH, Song HK,
Kim HK and Cha DR: Role of the VEGF 936 C/T polymorphism in
diabetic microvascular complications in type 2 diabetic patients.
Nephrology (Carlton). 14:681–688. 2009. View Article : Google Scholar
|
|
38
|
Awata T, Inoue K, Kurihara S, Ohkubo T,
Watanabe M, Inukai K, Inoue I and Katayama S: A common polymorphism
in the 5-untranslated region of the VEGF gene is associated with
diabetic retinopathy in type 2 diabetes. Diabetes. 51:1635–1639.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang X, Deng Y, Gu H, Lim A, Altankhuyag
A, Jia W, Ma K, Xu J, Zou Y, Snellingen T, et al: Polymorphisms in
the vascular endothelial growth factor gene and the risk of
diabetic retinopathy in Chinese patients with type 2 diabetes. Mol
Vis. 17:3088–3096. 2011.PubMed/NCBI
|
|
40
|
Kangas-Kontio T, Vavuli S, Kakko SJ, Penna
J, Savolainen ER, Savolainen MJ and Liinamaa MJ: Polymorphism of
the manganese superoxide dismutase gene but not of vascular
endothelial growth factor gene is a risk factor for diabetic
retinopathy. Br J Ophthalmol. 93:1401–1406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Uthra S, Raman R, Mukesh BN, Rajkumar SA,
Padmaja KR, Paul PG, Lakshmipathy P, Gnanamoorthy P, Sharma T,
McCarty CA, et al: Association of VEGF gene polymorphisms with
diabetic retinopathy in a south Indian cohort. Ophthalmic Genet.
29:11–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Motawi TK, Rizk SM, Ibrahim IA and
El-Emady YF: Alterations in circulating angiogenic and
anti-angiogenic factors in type 2 diabetic patients with
neuropathy. Cell Biochem Funct. 32:155–163. 2014. View Article : Google Scholar
|
|
43
|
Drela E, Stankowska K, Kulwas A and Rość
D: Endothelial progenitor cells in diabetic foot syndrome. Adv Clin
Exp. 21:249–254. 2012.
|
|
44
|
Deguchi T, Hashiguchi T, Horinouchi S, Uto
T, Oku H, Kimura K, Makisumi K and Arimura K: Serum VEGF increases
in diabetic polyneuropathy, particularly in the neurologically
active symptomatic stage. Diabet Med. 26:247–252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bleda S, De Haro J, Varela C, Esparza L,
Ferruelo A and Acin F: Vascular endothelial growth factor
polymorphisms are involved in the late vascular complications in
Type II diabetic patients. Diab Vasc Dis Res. 9:68–74. 2012.
View Article : Google Scholar
|
|
46
|
Ferrara N: Vascular endothelial growth
factor: Basic science and clinical progress. Endocr Rev.
25:581–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Costa PZ and Soares R: Neovascularization
in diabetes and its complications. Unraveling the angiogenic
paradox. Life Sci. 92:1037–1045. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wirostko B, Wong TY and Simó R: Vascular
endothelial growth factor and diabetic complications. Prog Retin
Eye Res. 27:608–621. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim YK, Lee M, Son SM, Kim IJ, Lee WS,
Rhim BY, Hong KW and Kim CD: Vascular NADH Oxidase is involved in
impaired endothelium-dependent vasodilatation in OLETF rats, a
model of type 2 diabetes. Diabetes. 51:522–527. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun Q, Yin Y, Zhu Z and Yan Z: Association
of the C242T polymorphism in the NAD(P)H oxidase P22 phox gene with
type 2 diabetes mellitus risk: A meta-analysis. Curr Med Res Opin.
30:415–422. 2014. View Article : Google Scholar
|
|
51
|
San José G, Fortuño A, Beloqui O, Díez J
and Zalba G: NADPH oxidase CYBA polymorphisms, oxidative stress and
cardiovascular diseases. Clin Sci (Lond). 114:173–182. 2008.
View Article : Google Scholar
|
|
52
|
Di Castelnuovo A, Soccio M, Iacoviello L,
Evangelista V, Consoli A, Vanuzzo D, Diviacco S, Carluccio M,
Rignanese L and De Caterina R: The C242T polymorphism of the
p22phox component of NAD(P)H oxidase and vascular risk. Two
case-control studies and a meta-analysis. Thromb Haemost.
99:594–601. 2008.PubMed/NCBI
|
|
53
|
Schreiber R, Ferreira-Sae MC, Tucunduva
AC, Mill JG, Costa FO, Krieger JE, Franchini KG, Pereira AC and
Nadruz W Jr: CYBA C242T polymorphism is associated with obesity and
diabetes mellitus in Brazilian hypertensive patients. Diabet Med.
29:e55–e61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kassab A and Piwowar A: Cell oxidant
stress delivery and cell dysfunction onset in type 2 diabetes.
Biochimie. 94:1837–1848. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Schreiber R, Bellinazzi VR, Sposito AC,
Mill JG, Krieger JE, Pereira AC and Nadruz W Jr: Influence of the
C242T polymorphism of the p22-phox gene (CYBA) on the interaction
between urinary sodium excretion and blood pressure in an urban
Brazilian population. PLoS One. 8:e810542013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Goliasch G, Wiesbauer F, Grafl A,
Ponweiser E, Blessberger H, Tentzeris I, Wojta J, Schillinger M,
Huber K, Maurer G, et al: The effect of p22-PHOX (CYBA)
polymorphisms on premature coronary artery disease (≤40 years of
age). Thromb Haemost. 105:529–534. 2011. View Article : Google Scholar
|
|
57
|
Xaplanteris P, Vlachopoulos C, Baou K,
Vassiliadou C, Dima I, Ioakeimidis N and Stefanadis C: The effect
of p22(phox) -930A/G, A640G and C242T polymorphisms of NADPH
oxidase on peripheral and central pressures in healthy,
normotensive individuals. Hypertens Res. 33:814–818. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Narne P, Ponnaluri KC, Singh S, Siraj M
and Ishaq M: Relationship between NADPH oxidase p22phox C242T,
PARP-1 Val762Ala polymorphisms, angiographically verified coronary
artery disease and myocardial infarction in South Indian patients
with type 2 diabetes mellitus. Thromb Res. 130:e259–e265. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Naka KK, Papathanassiou K, Bechlioulis A,
Kazakos N, Pappas K, Tigas S, Makriyiannis D, Tsatsoulis A and
Michalis LK: Determinants of vascular function in patients with
type 2 diabetes. Cardiovasc Diabetol. 11:1272012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pirola L, Balcerczyk A, Okabe J and
El-Osta A: Epigenetic phenomena linked to diabetic complications.
Nat Rev Endocrinol. 6:665–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
